Paving The Way Towards Carbon Neutral eCOA Trials

COVID-19 led businesses to adopt new practices, including moving many operations online and leading to a positive impact on CO₂ emission reductions. The clinical trials industry is no exception and is also able to accommodate such change. The timing is right to introduce additional carbon-efficient solutions to clinical trials. This article explores on how to improve eCOA trials carbon footprint.

To learn more about Kayentis, visit https://www.clinicalleader.com/ecommcenter/kayentis.